166 related articles for article (PubMed ID: 36420188)
1. Second Primary Malignancies in Diffuse Large B-cell Lymphoma Survivors with 40 Years of Follow Up: Influence of Chemotherapy and Radiation Therapy.
Rock CB; Chipman JJ; Parsons MW; Weil CR; Hutten RJ; Tao R; Tward JD; Shah HR; Hu B; Stephens DM; Gaffney DK
Adv Radiat Oncol; 2022; 7(6):101035. PubMed ID: 36420188
[TBL] [Abstract][Full Text] [Related]
2. Risk and subtypes of secondary primary malignancies in diffuse large B-cell lymphoma survivors change over time based on stage at diagnosis.
Major A; Smith DE; Ghosh D; Rabinovitch R; Kamdar M
Cancer; 2020 Jan; 126(1):189-201. PubMed ID: 31509235
[TBL] [Abstract][Full Text] [Related]
3. The impact of age at the time of radiotherapy for localized prostate cancer on the development of second primary malignancies.
Krasnow RE; RodrÃguez D; Nagle RT; Mossanen M; Kibel AS; Chang SL
Urol Oncol; 2018 Nov; 36(11):500.e11-500.e19. PubMed ID: 30249519
[TBL] [Abstract][Full Text] [Related]
4. Second primary malignancy in diffuse large B-cell lymphoma patients: A SEER database analysis.
Jiang S; Zhen H; Jiang H
Curr Probl Cancer; 2020 Feb; 44(1):100502. PubMed ID: 31537411
[TBL] [Abstract][Full Text] [Related]
5. Incidence and risk outcomes of second primary malignancy of patients with post-operative colorectal cancer.
Yang J; Wu F; An H; Gan H
Int J Colorectal Dis; 2023 Mar; 38(1):88. PubMed ID: 36995483
[TBL] [Abstract][Full Text] [Related]
6. Incidence and mortality of second primary malignancies after lymphoma: a population-based analysis.
Liu Y; Chu Y; Liu J; Ge X; Ding M; Li P; Liu F; Zhou X; Wang X
Ann Med; 2023; 55(2):2282652. PubMed ID: 38010751
[TBL] [Abstract][Full Text] [Related]
7. Subsequent primary malignancies after diffuse large B-cell lymphoma in the modern treatment era.
Tao L; Clarke CA; Rosenberg AS; Advani RH; Jonas BA; Flowers CR; Keegan THM
Br J Haematol; 2017 Jul; 178(1):72-80. PubMed ID: 28542862
[TBL] [Abstract][Full Text] [Related]
8. Second Primary Malignancies in Patients with Colorectal Cancer: A Population-Based Analysis.
Jia H; Li Q; Yuan J; Sun X; Wu Z
Oncologist; 2020 Apr; 25(4):e644-e650. PubMed ID: 31943509
[TBL] [Abstract][Full Text] [Related]
9. Exploring the risk of second primary malignancies in laryngeal cancer survivors: insights from the SEER database.
Afify AY; Ashry MH
Eur Arch Otorhinolaryngol; 2024 May; ():. PubMed ID: 38775833
[TBL] [Abstract][Full Text] [Related]
10. Incidence of second primary malignancies in relapsed/refractory B-cell non-Hodgkin's lymphoma patients in England.
Miret M; Anderson A; Hindocha P; Cirneanu L; Lymperopoulou C; Markov E; Kizito W; Vegni FE
Leuk Res; 2023 Apr; 127():107042. PubMed ID: 36812661
[TBL] [Abstract][Full Text] [Related]
11. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
[TBL] [Abstract][Full Text] [Related]
12. Second Primary Malignancy Risk in Multiple Myeloma from 1975 to 2018.
Wang J; Lv C; Zhou M; Xu JY; Chen B; Wan Y
Cancers (Basel); 2022 Oct; 14(19):. PubMed ID: 36230842
[TBL] [Abstract][Full Text] [Related]
13. Role of Radiation Therapy Differs Between Stages in Primary Bone Large B-Cell Lymphoma in Rituximab Era: A Population-Based Analysis.
Ma S; Zhang Y; Li Z; Yan H; Xia L; Shi W; Hu Y
Front Oncol; 2020; 10():1157. PubMed ID: 32760674
[No Abstract] [Full Text] [Related]
14. A population-based study of subsequent primary malignancies after endometrial cancer: genetic, environmental, and treatment-related associations.
Brown AP; Neeley ES; Werner T; Soisson AP; Burt RW; Gaffney DK
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):127-35. PubMed ID: 19910129
[TBL] [Abstract][Full Text] [Related]
15. Rituximab is not associated with increased risk of second primary malignancies in Israeli patients with diffuse large B cell lymphoma treated with RCHOP regimen.
Neeman Y; Perry C; Silverman B; Waintraub N; Avivi I
Leuk Lymphoma; 2020 Nov; 61(11):2638-2644. PubMed ID: 32611210
[TBL] [Abstract][Full Text] [Related]
16. Incidence features of second primary malignancy among gastric cancer survivors, 1992-2012.
Li S; Luo Y; Hou Q; Chu H; Zheng H
Transl Cancer Res; 2020 Nov; 9(11):7001-7011. PubMed ID: 35117306
[TBL] [Abstract][Full Text] [Related]
17. Second primary malignancies after ocular adnexal lymphoma diagnosis.
Loya A; Ramachandran V; Ayaz T; Weng CY
BMC Ophthalmol; 2021 Apr; 21(1):162. PubMed ID: 33827494
[TBL] [Abstract][Full Text] [Related]
18. Risk Assessment of Secondary Primary Malignancies in Nasopharyngeal Carcinoma: A Big-Data Intelligence Platform-Based Analysis of 6,377 Long-term Survivors from an Endemic Area Treated with Intensity-Modulated Radiation Therapy during 2003-2013.
Zhang LL; Li GH; Li YY; Qi ZY; Lin AH; Sun Y
Cancer Res Treat; 2019 Jul; 51(3):982-991. PubMed ID: 30309219
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Diabetes Mellitus on the Second Primary Malignancies in Colorectal Cancer Patients.
Halamkova J; Kazda T; Pehalova L; Gonec R; Kozakova S; Bohovicova L; Slaby O; Demlova R; Svoboda M; Kiss I
Front Oncol; 2020; 10():573394. PubMed ID: 33585194
[TBL] [Abstract][Full Text] [Related]
20. Assessment of second primary malignancies among treated and untreated patients with chronic lymphocytic leukemia using real-world data from the USA.
Ailawadhi S; Ravelo A; Ng CD; Shah B; Lamarre N; Wang R; Eakle K; Biondo JM
J Comp Eff Res; 2024 Feb; 13(2):e230119. PubMed ID: 38294335
[No Abstract] [Full Text] [Related]
[Next] [New Search]
